Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Daytime Body Rhythms in Breath Chemicals of People With and Without Diabetes

Measures breath chemicals during the day in adults with and without diabetes.

Plain-language title generated from the registry record
Registry title: The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes

Key facts

Where
Bern, SwitzerlandSee the site

Where in Switzerland

  • University of BernBern, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Bern
Trial code
NCT05984979
Record updated
8 December 2025
Original description
Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people will be recruited for the study.Read full original descriptionShow less

The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and With Type 1 and 2 Diabetes: an Exploratory Study

Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people will be recruited for the study.

Inclusion: Subgroup 1:; Age 18 or older; HbA1c below 6.5%; Written informed consent; Subgroup 2:; Age 18 or older; T1D (Type 1 diabetes) with MDI (multiple daily injection) or CSII (Continuous subcutaneous insulin infusion therapy) therapy >1 year; Written informed consent; Subgroup 3; Age 18 or older; T2D (Type 2 diabetes) with oral antidiabetic medication or insulin therapy; Written informed consent.

Exclusion: Antibiotic treatment in the previous 4 months; Any chronical lung and intestinal disease diagnosis (such as intestinal bowel disease (IBD); asthma; COPD (chronic obstructive pulmonary disease); lung cancer, …); Coeliac disease; Any acute disease diagnosis (such as viral or bacterial infection); Pregnancy or breastfeeding; Smoking (last cigarette less than 6 months ago); Lactose and fructose intolerance; Drinking habit of more than four units of alcohol per day; Current inhaled medicines treatments.

ClinicalTrials.gov NCT05984979